Alex K. Shalek’s lab at MIT specializes in developing and applying single-cell RNA-sequencing technologies to uncover subtle molecular differences between individual cells within tissues. This approach allows researchers to understand how each cell contributes to overall tissue function and how environmental factors influence cell identity. The lab’s work has spanned diverse areas, including cancer cell states, SARS-CoV-2 targets, and immune responses in allergies. This research is profoundly important because it provides a granular understanding of cellular mechanisms underlying complex global diseases like HIV, tuberculosis, and cancer. By dissecting these ‘tiny differences,’ the Shalek Lab’s technologies, such as the portable Seq-well platform, are crucial for developing more precise diagnostics and therapies, fostering global collaborations, and ultimately advancing human health worldwide.
Read Alex’s new profile in MIT News here.